1d
Vietnam Investment Review on MSNWuXi Biologics Posts Strong 2024 Results Forecasts Rapid Growth in 2025Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) service company offering end-to-end solutions for ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
1 Day WXIBF 4.23% DJIA 0.92% S&P 500 1.08% Health Care/Life Sciences 0.19% ...
1 Day WXXWY 0.91% DJIA 1.14% S&P 500 1.39% Health Care/Life Sciences 0.19% ...
As of 10:20:48 AM EST. Market Open.
**NM signifies a non meaningful value. A dash signifies the data is not available.
3759.HK Pharmaron Beijing Co., Ltd.
2696.HK Shanghai Henlius Biotech, Inc.
At close: 21 March at 16:00:00 GMT-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results